Serina Therapeutics (SER) Change in Receivables (2018 - 2023)
Serina Therapeutics' (SER) quarterly Change in Receivables came in at -$10000.0 in Q4 2023, down 433.33% year-over-year from $3000.0 in Q4 2022, and down 116.39% quarter-over-quarter from $61000.0 in Q3 2023.
Powered by 
Analysis
Serina Therapeutics (SER) Change in Receivables (2018 - 2023) Analysis & Trends
Serina Therapeutics has disclosed Change in Receivables across 6 years of filings, most recently posting -$10000.0 for Q4 2023.
- In Q4 2023, Change in Receivables fell 433.33% year-over-year to -$10000.0; the TTM figure through Dec 2023 stood at $53000.0 (up 352.38% YoY), while the FY2023 annual figure was $53000.0, up 352.38% from the prior year.
- Change in Receivables came in at -$10000.0 for Q4 2023 at Serina Therapeutics, down from $61000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $129000.0 in Q4 2019 to a low of -$105000.0 in Q1 2021.
- Average Change in Receivables over 5 years is $8300.0, with a median of $1500.0 recorded in 2019.
- Year-over-year, Change in Receivables slumped 3650.0% in 2020 and soared 654.55% in 2023.
- Over 5 years, Change in Receivables stood at $129000.0 in 2019, then retreated by 3.88% to $124000.0 in 2020, then slumped by 99.19% to $1000.0 in 2021, then soared by 200.0% to $3000.0 in 2022, then sank by 433.33% to -$10000.0 in 2023.
- Per Business Quant data, the three most recent Change in Receivables figures were -$10000.0 in Q4 2023, $61000.0 in Q3 2023, and -$1000.0 in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1.09 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 333.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 140.20 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 838.50 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -53.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 269.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Serina Therapeutics | 40.47 Mn | 17.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -10,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | -11,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Mar 31, 2022 | -25,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | -37,000.00 |
| Mar 31, 2021 | -105,000.00 |
| Dec 31, 2020 | 124,000.00 |
| Sep 30, 2020 | -12,000.00 |
| Jun 30, 2020 | -71,000.00 |
| Mar 31, 2020 | -11,000.00 |
| Dec 31, 2019 | 129,000.00 |
| Sep 30, 2019 | 26,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Mar 31, 2019 | 75,000.00 |